ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.510
+0.050 (3.42%)
At close: Dec 20, 2024, 4:00 PM
1.624
+0.114 (7.54%)
After-hours: Dec 20, 2024, 7:01 PM EST
ProKidney Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 40.58 | 44.82 | 70.94 | 8.86 | 5.98 | 4.16 |
| Research & Development | 110.42 | 106.71 | 82.07 | 46.26 | 21.04 | 15 |
| Operating Expenses | 150.99 | 151.52 | 153.01 | 55.11 | 27.02 | 19.16 |
| Operating Income | -150.99 | -151.52 | -153.01 | -55.11 | -27.02 | -19.16 |
| Interest Expense | -0.01 | -0.01 | -0.22 | - | - | - |
| Interest & Investment Income | 20.24 | 22.08 | 5.98 | 0 | 0.04 | 0.13 |
| EBT Excluding Unusual Items | -130.76 | -129.45 | -147.24 | -55.11 | -26.98 | -19.03 |
| Pretax Income | -136.09 | -129.45 | -147.24 | -55.11 | -26.98 | -79.25 |
| Income Tax Expense | 0.49 | 6 | 0.9 | 0.04 | -0.23 | 0.36 |
| Earnings From Continuing Operations | -136.58 | -135.45 | -148.14 | -55.15 | -26.75 | -79.62 |
| Minority Interest in Earnings | 90.97 | 99.98 | 40.1 | - | - | - |
| Net Income | -45.61 | -35.47 | -108.03 | -55.15 | -26.75 | -79.62 |
| Preferred Dividends & Other Adjustments | - | - | -93.63 | - | - | - |
| Net Income to Common | -45.61 | -35.47 | -14.4 | -55.15 | -26.75 | -79.62 |
| Shares Outstanding (Basic) | 81 | 62 | 62 | 151 | 105 | 79 |
| Shares Outstanding (Diluted) | 81 | 62 | 62 | 151 | 105 | 79 |
| Shares Change (YoY) | 32.24% | 0.28% | -59.17% | 43.55% | 33.70% | - |
| EPS (Basic) | -0.56 | -0.57 | -0.23 | -0.37 | -0.25 | -1.01 |
| EPS (Diluted) | -0.56 | -0.57 | -0.23 | -0.37 | -0.25 | -1.01 |
| Free Cash Flow | -133.14 | -124.27 | -78.94 | -55.49 | -30.64 | -78.11 |
| Free Cash Flow Per Share | -1.64 | -2.01 | -1.28 | -0.37 | -0.29 | -0.99 |
| EBITDA | -145.99 | -147.67 | -149.97 | -53.13 | -26.06 | -18.29 |
| D&A For EBITDA | 5 | 3.85 | 3.04 | 1.98 | 0.96 | 0.87 |
| EBIT | -150.99 | -151.52 | -153.01 | -55.11 | -27.02 | -19.16 |
Source: S&P Capital IQ. Standard template.
Financial Sources.